Blood and neoplastic diseases. Rational approach to the chemotherapy of human malignant disease-II.
D000970:Antineoplastic Agents / Q000378:metabolism; D001932:Brain Neoplasms / Q000188:drug therapy; D002066:Busulfan / Q000627:therapeutic use; D002452:Cell Count; D002455:Cell Division; D003561:Cytarabine / Q000627:therapeutic use; D004058:Diffusion; D004361:Drug Tolerance; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007958:Leukocyte Count; D008223:Lymphoma / Q000188:drug therapy; D008727:Methotrexate / Q000378:metabolism; D009101:Multiple Myeloma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D014750:Vincristine; D002066:Busulfan; D008727:Methotrexate